Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2000
12/28/2000WO2000078964A1 Glycoprotein hormone family member
12/28/2000WO2000078963A1 Serin proteinase inhibitors
12/28/2000WO2000078960A2 Compositions and methods for the therapy and diagnosis of breast cancer
12/28/2000WO2000078959A1 Human genes and proteins encoded thereby
12/28/2000WO2000078956A1 Novel pyrrhocoricin-derived peptides, and methods of use thereof
12/28/2000WO2000078955A1 Epithelial cell growth inhibitors
12/28/2000WO2000078954A2 Human transcriptional regulator proteins
12/28/2000WO2000078953A2 Human transport proteins
12/28/2000WO2000078952A2 Human rna metabolism proteins (rmep)
12/28/2000WO2000078949A1 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
12/28/2000WO2000078948A2 Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor
12/28/2000WO2000078946A2 Treatment of viral influenza with antisense oligonucleotides
12/28/2000WO2000078941A2 Methods and products for manipulating uncoupling protein expression
12/28/2000WO2000078937A1 Methods for ameliorating icthyosiform skin diseases
12/28/2000WO2000078933A2 Novel calpains and their use
12/28/2000WO2000078930A1 Method for enhancing hematopoiesis
12/28/2000WO2000078927A2 Spheroid preparation
12/28/2000WO2000078812A1 Method and compounds for inhibiting activity of serine elastases
12/28/2000WO2000078811A1 Human antithrombin variants
12/28/2000WO2000078810A1 Surfactant protein c esters
12/28/2000WO2000078806A1 Mage-a1 peptides presented by hla class ii molecules
12/28/2000WO2000078805A1 Peptide having preptin functionality
12/28/2000WO2000078804A1 Immune response regulatory proteins
12/28/2000WO2000078803A2 Use of eif4e binding agents in therapy
12/28/2000WO2000078802A2 Secreted polypeptides and corresponding polynucleotides
12/28/2000WO2000078801A2 Insulin-like growth factor agonist molecules
12/28/2000WO2000078797A1 Rufomycin derivatives useful as antibiotics
12/28/2000WO2000078796A2 Labeled neurotensin derivatives with improved resistance to enzymatic degradation
12/28/2000WO2000078795A2 Rufomycins and derivatives thereof useful as inhibitors of multi-drug resistance associated protein-1 (mrp-1)
12/28/2000WO2000078794A1 Cysteinyl protease inhibitors
12/28/2000WO2000078793A2 Antimicrobial agents
12/28/2000WO2000078792A1 Method for purification of proteins
12/28/2000WO2000078788A1 NOVEL cDNA ASSOCIATED WITH RENAL DISEASE
12/28/2000WO2000078786A1 galK
12/28/2000WO2000078785A1 lacA
12/28/2000WO2000078783A1 Fucose kinase
12/28/2000WO2000078780A1 FabZ
12/28/2000WO2000078360A1 Compositions and methods for the treatment or prevention of autoimmune disorders
12/28/2000WO2000078358A2 Hyaluronic acid microspheres for sustained gene transfer
12/28/2000WO2000078357A2 Hyaluronic acid film and matrix for sustained gene transfer
12/28/2000WO2000078356A1 Injectable hyaluronate-sulfated polysaccharide conjugates
12/28/2000WO2000078347A1 Cell growth inhibition
12/28/2000WO2000078346A1 Novel anti-allergic agents
12/28/2000WO2000078344A1 Prion protein peptides and uses thereof
12/28/2000WO2000078342A1 Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
12/28/2000WO2000078341A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000WO2000078340A1 Sustained release preparations of physiologically active peptides
12/28/2000WO2000078339A1 Uterine contraction inhibitors
12/28/2000WO2000078338A1 Compositions for promoting passive elongation of vesical smooth muscle
12/28/2000WO2000078337A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies
12/28/2000WO2000078336A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
12/28/2000WO2000078335A1 COMPOSITIONS FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS
12/28/2000WO2000078333A2 Synergetic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependant diabetes
12/28/2000WO2000078332A2 Fish serine proteinases and their pharmaceutical and cosmetic use
12/28/2000WO2000078331A2 Il6ril6 chimera for the treatment of neurodegenerative diseases
12/28/2000WO2000078330A2 Adenosine diphosphatase and activators thereof and their medical uses
12/28/2000WO2000078329A2 The use of the protein uk 114 for inhibiting organ transplant rejection
12/28/2000WO2000078328A2 USE OF GROWTH HORMONE (hGH) FOR THE TREATMENT OF SEXUAL FUNCTIONAL DISTURBANCES
12/28/2000WO2000078327A2 Agents for treating malignant diseases using e1a-deficient adenoviruses with yb-1 protein-dependent replication
12/28/2000WO2000078321A1 Agent for regulating iodine exchange or for preventing iodine-deficit conditions
12/28/2000WO2000078311A1 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
12/28/2000WO2000078302A1 Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same
12/28/2000WO2000078266A2 Interferon tau mutants and methods for making them
12/28/2000WO2000078259A1 Enhanced wound coverage to enhance wound healing
12/28/2000WO2000078247A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
12/28/2000WO2000078119A2 Cardiomyocytes with enhanced proliferative potential
12/28/2000WO2000058460A3 Casb619 involved in colon cancers
12/28/2000WO2000056354A3 Methods of using agents that act on the epithelial sheet of a human eye
12/28/2000WO2000056353A3 A uro-genital condition treatment system
12/28/2000WO2000053735A3 Methods for identifying modulators of synaptic plasticity and cell motility
12/28/2000WO2000051624A3 Methods and compositions useful in inhibiting apoptosis
12/28/2000WO2000048625A3 Inhibitors for use in hemostasis and immune function
12/28/2000WO2000048614A3 Method for producing anti-tumor th1 cells
12/28/2000WO2000046344A3 Non-stochastic generation of genetic vaccines and enzymes
12/28/2000WO2000045851A3 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
12/28/2000WO2000043495A3 33 human secreted proteins
12/28/2000WO2000043034A3 Monodisperse hexameric acylated insulin analog formulations
12/28/2000WO2000037640A3 Compositions and methods for the treatment of tumor
12/28/2000WO2000034474A3 Growth factor homolog zvegf3
12/28/2000WO2000034315A3 Purification of echinocandin cyclopeptide compounds
12/28/2000WO2000032776A3 Secreted amd transmembrane polypeptides and nucleic acids encoding the same
12/28/2000WO2000030667A3 Compositions and methods using lactadherin or variants thereof
12/28/2000WO2000024774A3 Growth factor related molecules
12/28/2000WO2000017369B1 Alzheimer's disease secretase
12/28/2000WO2000014198A3 Isolation of human pemt2 gene and methods for diagnosing and treating liver disorders
12/28/2000DE19929569A1 Composition for treating malignant disease, comprising E1A-defective adenovirus that can replicate in presence of YB-1 protein
12/28/2000DE19929410A1 New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis
12/28/2000DE19928417A1 New gene encoding the G-protein coupled receptor hLPACR1, useful for diagnosis and gene therapy treatment of associated diseases
12/28/2000CA2778826A1 Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same
12/28/2000CA2382425A1 Interferon tau mutants and methods for making them
12/28/2000CA2377648A1 Prion protein peptides and uses thereof
12/28/2000CA2377639A1 The use of the protein uk 114 for inhibiting organ transplant rejection
12/28/2000CA2377530A1 Compositions and methods for the treatment or prevention of autoimmune disorders
12/28/2000CA2377524A1 Novel anti-allergic agents
12/28/2000CA2377517A1 Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same
12/28/2000CA2377371A1 Enhanced wound coverage to enhance wound healing
12/28/2000CA2377357A1 Fish serine proteinases and their pharmaceutical and cosmetic use
12/28/2000CA2377339A1 Administration of growth hormone (hgh) for the therapy of sexual functional disorders
12/28/2000CA2377270A1 Cardiomyocytes with enhanced proliferative potential
12/28/2000CA2377263A1 Polynucleotides and polypeptides encoded thereby
1 ... 2308 2309 2310 2311 2312 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 ... 3163